Retension Pharmaceuticals: director Franklin M Berger received 5,636 shares

What happened Franklin M Berger, a director, received a stock option award for 5,636 shares (derivative security) at $0.00 per share, total $0.00, on Oct 8, 2026. The transaction is reported as code A (award/grant).

Key details

• Transaction date and price: Oct 8, 2026; $0.00 per share; total $0.00.
• Shares owned after the transaction: not reported in this Form 4.
• Footnote F1: option award granted under the issuer's 2026 Equity Incentive Plan; 25% of the option vests on the first anniversary of grant, with the remaining options vesting in 12 quarterly increments thereafter, subject to continued service.
• Filing: Form 4 filed on Oct 8, 2026; no late filing indicated in the document.

Why it may matter This was a stock option award, not an option exercise or a market sale, so no shares were sold as part of this transaction. The filing does not show why the insider traded or why the company acted.